| Financial Year |
March 31 2023 |
| Monetary Funds |
5,948,969,974.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,654,658,202.95 |
| Advances to Suppliers |
3,501,528,015.46 |
| Other Receivables |
7,195,802,675.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
42,306,343,900.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,166,443,341.32 |
| Total Current Assets |
61,813,774,747.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,137,944,590.89 |
| Investment Properties |
56,506,361.00 |
| Fixed Assetes |
791,344,942.02 |
| Under-construction Projects |
549,205,608.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
571,929,309.22 |
| R&D expenses |
-- |
| Goodwill |
230,587.52 |
| Long-Term Deferred and Prepaid Expenses |
33,288,616.63 |
| Deferred Income Tax Assets |
414,963,061.09 |
| Other Non-Current Assets |
77,917,993.30 |
| Sub-Total of Non-Current Assets |
4,743,160,291.57 |
| Total Assets |
66,556,935,039.55 |
| Short-Term Loans |
756,819,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
8,087,515,164.28 |
| Accounts Received In Advance |
16,235,573.92 |
| Employee Compensation Payable |
45,036,762.19 |
| Taxes Payable |
1,016,148,126.14 |
| Interest Payable |
-- |
| Dividend Payable |
42,444,796.18 |
| Other payables |
5,409,411,979.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,606,576,898.56 |
| Other Current Liabilities |
1,631,215,072.54 |
| Sub-Total of Current Liabilities |
25,508,142,077.80 |
| Long-term Loans |
24,522,376,380.00 |
| Bonds Payable |
4,400,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,453,562.04 |
| Deferred Income Tax Liabilities |
228,970,501.01 |
| Other Non-Current Liabilities |
15,996,299.51 |
| Sub-Total of Non-Current Liabilities |
29,295,950,338.07 |
| Total Liabilities |
54,804,092,415.87 |
| Paid-In Capital(Or Share Stock) |
2,228,636,743.00 |
| Capital Surplus |
1,271,806,856.40 |
| Surplus Reserve |
844,329,244.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,462,673,506.03 |
| Minority Stockholder's Interest |
945,396,273.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,807,446,350.35 |
| Owner's Equity（Stockholder's Equity） |
11,752,842,623.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
66,556,935,039.55 |
